Skip to main content
Diagnostic and Interventional Radiology logoLink to Diagnostic and Interventional Radiology
. 2022 Sep 1;28(5):403–409. doi: 10.5152/dir.2022.201112

Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer

Andelib Babatürk  1, Ayşe Erden  1, İbrahim Ethem Geçim  1
PMCID: PMC9682593  PMID: 35997474

Abstract

PURPOSE

This study aimed to retrospectively evaluate the apparent diffusion coefficient (ADC) histograms in predicting chemoradiotherapy (CRT) response in patients with locally advanced rectal cancer (LARC).

METHODS

A total of 51 patients who underwent surgery in our institution for rectal cancer following neoadjuvant CRT between November 2013 and July 2019 were enrolled. Conventional magnetic resonance (MR) and diffusion-weighted images obtained before and after CRT were evaluated retrospectively. All tumor-containing regions of interests were drawn in 3 selected axial images, and special software for histogram analysis was used to evaluate ADC distribution. ADC cutoff values from post-CRT ADC histogram were calculated from receiver operating characteristic (ROC) analysis for evaluating CRT response.

RESULTS

In histopathological analysis, 5 patients (9.8%) had minimal response (group 1), 31 patients (60.8%) had partial response (group 2), and 15 patients (29.4%) had complete or almost complete response (group 3). In the ADC histogram, minimum, maximum, 10th, 25th, 50th, 75th, and 90th percentile, mean ADC values, and skewness values of groups 2 and 3 showed significant changes before and after CRT, but no difference was found within group 1 values. The mean, 25th, 50th, 75th percent ADC values after CRT and skewness, and kurtosis values were significantly different between group 1 and group 3. Skewness value from the ADC histogram in post-CRT magnetic resonance imaging had the best diagnostic performance with an area under the ROC curve of 0.851 (P = .003) for detecting group 3. The skewness cutoff calculated from the ROC analysis was 0.210 for evaluating CRT response. The sensitivity and specificity of the cut-off value were 100% and 61.4%, respectively.

CONCLUSION

The ADC histogram analysis seems to have potential application in predicting response to neoadjuvant CRT in patients with locally advanced rectal cancer.


Main points

  • In response to the chemoradiotherapy (CRT), a leftward skew of the histogram curve (negative skew), a decrease in the height of the histogram peak (negative kurtosis), and an increase in apparent diffusion coefficient values are observed.

  • Apparent diffusion coefficient histogram analysis seems to have potential application in predicting complete response to preoperative CRT in patients with locally advanced rectal cancer.

  • The post-CRT skewness value of 0.210 is highly sensitive in determining the response to neoadjuvant CRT.

Colorectal cancer is among the most important causes of cancer-related deaths worldwide.1 In the last few decades, the advanced surgical methods and neoadjuvant chemoradiotherapy (CRT) implementations have been shown to be useful in significantly reducing the local recurrence rates in locally advanced (stages T3-4 or node-positive tumor) rectal cancer. Neoadjuvant CRT not only can reduce the recurrence but also can downstage the tumor and increase the tumor resection and sphincter-preserving surgery rates.2-6

An accurate evaluation of response to neoadjuvant CRT is crucial because of its major effect on patient management. Although highly valuable in evaluating the primary tumor and its extension to the mesorectal fascia, conventional magnetic resonance imaging (MRI) has some limitations in distinguishing the residual tumor from post-treatment fibrosis.5 Diffusion-weighted imaging (DWI), on the other hand, is a non-invasive functional MRI technique and is sensitive to the motion of water molecules in biological tissues. It has high specificity in reflecting tissue cellularity, distinguishing post-treatment recurrence or residual tumor tissue from fibrosis or necrosis.6-9 Apparent diffusion coefficient (ADC) mapping is thought to contribute to predicting prognosis and response to neoadjuvant CRT.5,6,10,11 However, CRT-applied tumor tissue has a very heterogeneous microstructure composed of residual (viable) tumor cells, necrosis, fibrosis, and mucous substance. In addition, studies have shown the success of ADC values in determining tumor aggression in colon cancer.12

Literature data show that parameters derived from ADC histogram curves reflect tissue heterogeneity more precisely than mean ADC values.10-15 Histogram analysis which is a new approach to ADC measure is based on pixel distribution and can be used as a quantitative marker of the biological heterogeneity of the tumor. A spectrum of ADC values, such as minimum ADC, mean ADC, maximum ADC, various ADC percentiles, as well as statistical parameters, which consider the extremes of the data set rather than focusing solely on the average, like skewness and kurtosis can be estimated by using this method. In tumor restaging, changes in parameters of histogram analysis, compared to pre-CRT data, provide information about the microstructural heterogeneity of the tumor response.10,11 By applying histogram analysis to pre- and post-CRT images, the change in the microstructure of the tumor can be graphically visualized and quantified with descriptive parameters derived from the ADC histogram.13,14

The purpose of our study is to assess the effectiveness of ADC histogram analysis parameters in predicting response in rectal cancer patients who underwent neoadjuvant CRT.

Methods

The study protocol was approved by the institutional medical ethics committee of our hospital (decision number 04-230-18, dated February 26, 2018), and written informed consent was waived for this retrospective study.

Patients

Data were collected from our picture archiving and communication system in consecutive patients with rectal cancer. A total of 274 patients who were diagnosed with non-mucinous rectal adenocarcinoma by colonoscopic biopsy and underwent pelvic MRI in our radiology department between November 2013 and July 2019 were retrospectively evaluated. Mucinous adenocarcinomas were excluded in the initial assessment since ADC values of mucinous subtypes are considerably higher than that of non-mucinous carcinomas due to abundant mucin and low cellularity.16 After CRT, the necrosis of the viable malign cells of mucinous tumor results in a featureless fluid-like signal on the ADC map, and pre- and post-CRT ADCs can overlap.

Thereby, inclusion criteria consisted of histopathologically proven non-mucinous rectal adenocarcinoma, availability of a pretreatment local staging (pre-CRT) MRI, tumor stage higher than T2, long course neoadjuvant therapy, restaging (post-CRT) MRI, and data on the final response of treatment (based on histopathologic results obtained from the surgical specimen).

The following patients did not meet the inclusion criteria for this study and were therefore excluded from the study: (a) 68 patients had no primary staging MRI examination, (b) 103 patients had no restaging MRI, (c) 50 patients had not received the surgery or had surgery in another center, and (d) one patient had post-CRT MRI with low diagnostic quality. A final total study population of 51 patients remained.

The neoadjuvant treatment regime used in patients who were evaluated in the first years consisted of radiation to an average total dose of 45 Gy, divided into 5 days per week, a 28-day treatment period, and one boost of 5.4 Gy. This regimen was applied simultaneously with 5-fluorouracil (5-FU) at a dose of 350 mg/m2/day in the first and fifth weeks of radiation therapy. For the last 5 years, 5-FU infusion and radiation therapy were replaced by preoperative concurrent CRT (45 Gy/25 fractions over 5 weeks and on radiotherapy days 825 mg/m2 oral capecitabine twice daily), again followed by a boost of 5.4 Gy. Magnetic resonance imaging scans were performed after completion of CRT at an interval of 6-7 weeks, and surgery was undertaken at 8-9 weeks after CRT. The tumor regression grading (TRG) system proposed by Dworak17 was used for histopathological response assessment.

Patient preparation

In order not to stimulate intestinal peristalsis, a pelvic MRI was performed after at least 5-6 hours of fasting. Before the examination, bowel cleansing and antiperistaltic medication were not applied. No air, fluid, or rectal gel was administrated to achieve rectum distension.

MRI protocol

Magnetic resonance imaging examinations were performed with standard body matrix coil on a 3 Tesla imaging system (MAGNETOM Verio, Siemens Medical Solutions). Scan protocol used in this study was as follows: sagittal turbo spin-echo (TSE) T2-weighted (slice thickness: 3.5 mm; distance factor [DF]: 15%; repetition time [TR]: 4500 ms; echo time [TE]: 104 ms; echo trains per slice: 13; field-of-view [FOV]: 220 mm; flip angle [FA]: 120°; matrix: 384 × 307; number of signal averages [NSA]: 2; acquisition time: 4.05 minutes); axial TSE T2-weighted (slice thickness: 5.0 mm; DF: 20%; TR: 5450 ms; TE: 93 ms; echo trains per slice: 8; FA: 150°; FOV: 220 mm; matrix: 320 × 256; NSA: 3; acquisition time: 2.18 minutes); oblique axial high resolution (HR) TSE T2-weighted (slice thickness: 3.0 mm; DF: 16%; TR: 5460 ms; TE: 58 ms; echo trains per slice: 12; FA: 145°; FOV: 220 mm; matrix: 320 × 256; NSA: 4; acquisition time: 4:54 minutes); oblique coronal HR TSE T2-weighted (slice thickness: 3.0 mm; DF: 16%; TR: 5180 ms; TE: 58 ms; echo trains per slice: 15; FA: 135°; FOV: 220 mm; matrix: 320 × 256; NSA: 4; acquisition time: 6:00 minutes); oblique axial HR TSE contrast-enhanced fat suppressed T1-weighted (slice thickness: 3.5 mm; DF: 14%; TR: 495 ms; TE: 12 ms; echo trains per slice: 39; FA: 140°; FOV: 180 mm; matrix: 320 × 256; NSA: 3; acquisition time: 4:31 minutes); and oblique and coronal HR TSE contrast-enhanced fat suppressed T1-weighted images (DF: 14%; slice thickness: 3.5 mm; TR: 495 ms; TE: 12 ms; echo trains per slice: 39; FA: 140°; FOV: 180 mm; matrix: 320 × 256; NSA: 2; acquisition time: 3:35 minutes). The sagittal images were used for planning oblique axial and oblique coronal images, respectively, perpendicular and parallel to the long axis of the rectal tumor.

Axial-free breathing DWI was performed with 3 different b values (50, 400, and 1000 s/mm2) with a single-shot echo-planar imaging sequence and spectral attenuated inversion-recovery fat-suppression technique. Diffusion-weighted imaging parameters were as follows: slice thickness: 5.0 mm; DF: 30%; TR: 646 ms; TE: 11 ms; echo trains per slice: 47; FA: 140°; FOV: 180 mm; matrix: 320 × 288; NSA: 2; acquisition time: 3:06 minutes. Parallel imaging with a reduction factor of 2 was used in all sequences. The operating system automatically generated the apparent diffusion coefficient maps in the grayscale using a monoexponential decay model containing all 3 b values.

Image evaluation

Magnetic resonance images were transferred to the workstation (Syngo.via, Siemens Healthineers) and evaluated retrospectively. Measurements were made by a single observer, blinded to the patients’ clinical information and histopathology results. Since diffusion-weighted images have higher resolution than ADC maps, regions of interests (ROIs) were drawn to include the entire tumor from 3 different diffusion-weighted images, where the tumor is the largest and best seen in the axial plane. Later, these ROIs were copied to the ADC map. Special software (Syngo.via Oncology, Siemens Healthineers) was used for the ROI-based ADC histogram analysis. Minimum, mean, maximum ADC values, 10th, 25th, 50th, 75th, 90th percentiles, and skewness (asymmetry characterized by a right or left shift in the normal distribution curve) and kurtosis (a measure that describes the shape of a distribution's tails in relation to its overall shape) values were derived from ADC histograms. For each parameter, 3 measurements were averaged. The following equation was used to calculate the ADC change (ΔADC) between the groups before and after CRT: [(post-CRT ADC − pre-CRT ADC)/pre-CRT ADC] × 100.

Statistical analysis

Statistical analyses were performed using the Statistical Package for Social Sciences Version 23 program (IBM corp.). The compatibility of the quantitative data to normal distribution was tested by Shapiro–Wilk test and graphical analysis. Analysis of variance test was used to check whether the means of the 3 groups were significantly different from each other. The Student t-test was used for comparisons of normally distributed quantitative variables between 2 groups, and Mann–Whitney U test was used for comparisons of quantitative variables that did not show normal distribution between 2 groups. Paired samples t test was used for evaluating normally distributed variables before and after treatment. In the comparison of qualitative data, Pearson chi-square test, Fisher Freeman Halton test, and Fisher exact test were used. Receiver operator characteristics (ROC) analysis was used to determine the cutoff value according to the regression grade of the tumor. A P value less than .05 was considered indicative of a statistically significant difference.

Results

In this study, a total of 51 patients (13 women and 38 men) were included. The mean age of the patients was 59.2 years (age range: 20-85 years). Other demographic features are shown in Table 1. On histopathological response assessment, 5 patients (9.8%) had TRG 1 (minimal response), 31 patients (60.8%) had TRG 2 (partial response), 8 patients (15.6%) had TRG 3 (almost complete response), and 7 patients had (13.7%) TRG 4 (complete response). Since there was a heterogeneous distribution in numbers, TRG 3 and 4 were combined and the patients were analyzed under 3 groups as follows: patients with minimal response (group 1), partial response (group 2), and complete/almost complete response (group 3). Pre- and post-CRT minimum, maximum, mean ADC values, 10th, 25th, 50th, 75th, and 90th percentiles were calculated from the ADC histogram analysis, and the skewness and kurtosis values are shown in Table 2.

Table 1.

Patient demographics

n = 51 %
Primary T staging
T1 4 7.8
T2 3 5.9
T3 32 62.7
T4 12 23.5
Final T staging
ypT0 7 13.7
ypT1 1 2.0
ypT2 12 23.5
ypT3 27 52.9
ypT4 4 7.8
Final N staging
Nx 5 9.8
N0 35 68.6
N1a 3 5.9
N1b 2 3.9
N1c 2 3.9
N2a 0 0.0
N2b 4 7.8
Mesorectal fascia involvement
Present 16 31.4
Absent 26 51.0
Suspicious 9 17.6
Extramural venous invasion
Present 10 19.6
Absent 41 80.4

Table 2.

Pre- and post-CRT minimum, maximum, mean ± SD of ADC histogram analysis parameters, and skewness and kurtosis values

Pre-CRT Post-CRT
Minimum Maximum Mean ± SD Minimum Maximum Mean ± SD
Minimum 0.14 1.07 0.57 ± 0.18 0.19 1.77 0.87 ± 0.37
10th percentile 0.47 1.35 0.76 ± 0.15 0.57 1.99 1.05 ± 0.34
25th percentile 0.56 1.55 0.86 ± 0.17 0.61 2.14 1.16 ± 0.34
50th percentile 0.69 1.77 0.99 ± 0.19 0.68 2.37 1.34 ± 0.35
75th percentile 0.84 1.99 1.14 ± 0.22 0.77 2.48 1.51 ± 0.37
90th percentile 0.97 2.12 1.31 ± 0.24 0.87 2.56 1.66 ± 0.37
Maximum 1.18 2.35 1.67 ± 0.29 0.95 2.88 1.92 ± 0.39
Mean 0.72 1.76 1.02 ± 0.19 0.70 2.31 1.35 ± 0.35
Kurtosis −0.91 2.82 0.72 ± 0.82 −1.20 2.95 0.22 ± 0.83
Skewness −0.31 1.51 0.61 ± 0.40 −0.82 1.52 0.25 ± 0.48

ADC values are given in units of 10−3mm2/s.

CRT, chemoradiotherapy; SD, standard deviation; ADC, apparent diffusion coefficient.

The mean ± standard deviation (SD) pre-CRT tumor ADCmean value was 1.02 × 10−3 mm2/s ± 0.19, whereas the mean ± SD post-CRT ADCmean was 1.35 × 10−3 mm2/s ± 0.35. Considering all patients, the mean ADCmean value increased significantly after CRT. However, when the comparison was made between the groups, it was seen that this significant difference was caused by the groups showing partial response and the groups showing complete/almost complete response. There was no significant difference in any ADC measurements, including the mean ADCmean values before and after CRT in patients with minimal response.

Significant changes were observed before and after CRT in the skewness, minimum, 10th, 25th, 50th, 75th, and 90th percentile, mean and maximum values in groups 2 and 3 (P < .05) (Figure 1). However, no significant difference was found between pre- and post-CRT values of group 1 (Figure 2). Post-CRT mean, minimum, 10th, 25th, 50th, 75th, and 90th percentile, skewness and kurtosis values were significantly different (P < .05) between group 1 and group 3 (Table 3). There was no significant difference in the groups regarding the maximum ADC values. There was no statistical difference between patients with partial response (group 2) and group 1 or group 3 in terms of histogram ADC values.

Figure 1. a-f.

Figure 1. a-f.

Histogram analysis in 62-year-old man with complete response following neoadjuvant CRT for rectal cancer. Pre-CRT color-coded ADC map (a) and ADC histogram (b). Mean Pre-CRT ADC is 1.20. Color-code red voxels, ADC values < 1.050 × 10−3 mm2/s; yellow voxels 1.050-1.450 × 10−3 mm2/s; green voxels > 1.450 × 10−3 mm2/s. The normal distribution curve (c). Post-CRT color-coded ADC map (d). Left-skewed histogram curve after CRT (e): the mass of distribution concentrated on the right indicating an increase in the ADC values of voxels over the time points. Mean post-CRT is 1.45 × 10−3 mm2/s. Most voxels contain an ADC greater than the mean. The histogram has a flatter tail on the left. Negative skew diagram (f). CRT, chemoradiotherapy; ADC, apparent diffusion coefficient.

Figure 2. a-f.

Figure 2. a-f.

Histogram analysis in 79-year-old man with minimal response following neoadjuvant CRT for rectal cancer. Pre-CRT color-coded ADC map (a) and ADC histogram (b). The normal distribution curve (c). Post-CRT color-coded ADC map (d) and ADC histogram (e). After CRT, ADC changed from 0.9 to 1.0 × 10−3 mm2/s. The post-CRT ADC histogram demonstrates positive skewness. Most of the voxels are concentrated on the left of the graphic and contain ADC values less than the mean. The tail on the right side of the distribution is longer and flatter. The positive skew diagram (f).

Table 3.

Changes with respect to treatment response in ADC histogram data in groups 1 and 3

Differences in mean values P
Mean 464.78 .023
Minimum 458.74 .040
10th percentile 407.87 .047
25th percentile 458.07 .023
50th percentile 495.00 .015
75th percentile 510.43 .021
90th percentile 449.14 .047
Maximum −311.08 .276
Kurtosis 1.12 .023
Skewness 0.66 .020

ADC, apparent diffusion coefficient.

In 4 patients, post-CRT ADC values showed an unexpected decrease in the histogram analysis. In 2 of these 4 patients whose histograms were right-skewed, in the histopathologic examination of the resected specimens, there were no residual tumor cells (pathological complete response).

The post-CRT skewness value derived from the ADC histogram had the best diagnostic performance with an area of 0.851 (P =.003) under the ROC curve to identify patients with complete response (Table 4). To evaluate the CRT response, the cutoff skewness value calculated from the ROC analysis was determined as 0.210 with 100% sensitivity (95% CI: 56-100) and 61.4% specificity (95% CI: 46-75) (Figure 3).

Table 4.

Diagnostic performances of post-CRT ADC values and kurtosis and skewness in determining patients with complete response and minimal response

Complete response Minimal response
AUC P AUC P
Minimum .724 .059 .852 .010
10th percentile .718 .067 .774 .046
25th percentile .763 .027 .826 .018
50th percentile .766 .025 .835 .015
75th percentile .737 .046 .865 .008**
90th percentile .685 .119 .835 .015
Maximum .640 .239 .700 .145
Mean .744 .040 .843 .012
Kurtosis .601 .396 .826 .018
Skewness .851 .003* .822 .019

CRT, chemoradiotherapy; ADC, apparent diffusion coefficient; AUC, area under the curve.

*The post-CRT skewness value derived from the ADC histogram had the best diagnostic performance with an area of 0.851 (P = .003).

**The 75th percentile ADC values had the best diagnostic performance for detecting patients with minimal response.

Figure 3.

Figure 3.

ROC curve for skewness as predictor of complete response. ROC, receiver operating characteristic.

Patients with minimal response to treatment can be identified with the aid of ADC histogram analysis. The 75th percentile ADC values had the best diagnostic performance for discrimination group 1 (Table 4). From the ROC analysis, the limit 75th percentile ADC values were calculated as 1.35 × 10−3 mm2/s with 100% (95% CI:54-82) sensitivity and 70% (95% CI: 46-100) specificity.

There was a significant difference in ADC change (ΔADC) before and after CRT between the minimally responsive group and the group with complete/almost complete response (P = .04).

Discussion

In this single-center, retrospective ADC histogram analysis study, a leftward skew of the histogram curve (negative skew), a decrease in the height of the histogram peak (negative kurtosis), and an increase in ADC values are observed in response to the CRT. The post-CRT skewness value derived from the ADC histogram is highly sensitive in identifying patients with complete response. The 75th percentile ADC values had the best diagnostic performance for determining the patients with minimal response to treatment.

In locally advanced rectal cancer cases, neoadjuvant CRT before operative treatment provides higher rates of sphincter-sparing surgery, less-frequent anastomotic stenosis, and better local control than adjuvant regimens, while the long-term survival rates of both approaches are similar.18 The neoadjuvant regimen can also eradicate the tumor completely (complete response). In recent years, the opinion has come to the fore that selected patients who achieve a clinical complete response after neoadjuvant CRT can be followed up without surgery (watch-and-wait approach).19,20 For this reason, predicting the response to CRT is very important in terms of the treatment strategy.

Various studies have shown that MRI is quite successful in predicting the response to treatment.21,22 In a meta-analysis, it was found that MRI has 78% sensitivity and 81% specificity in predicting the response of tumor after preoperative treatment.22 Diffusion-weighted imaging can be added to the protocol to improve the diagnostic performance of MRI in restaging after CRT.5,6,11 In a study (involving 21 patients) conducted by Napoletano et al.,23 the sensitivity of conventional MRI is 80% and the specificity is 50% in response evaluation. In this study, the addition of DWI to the conventional MRI increased the sensitivity to 100% and the specificity to 67%, thereby improving the morphologic information provided by conventional examination. Visual assessment of signal changes on DWI and measurements from ADC map derived from DWI can differentiate post-treatment recurrence or residual tumor tissue from post-treatment changes or necrosis.5,6,10,11 However, according to the literature, data obtained from ADC histogram curves can represent tissue composition more sensitively in comparison to generally used ADCmean values.10,11,13,14 In tumor ADC measurements, ROI size and positioning significantly affect the measurement results, and small differences may result in non-negligible variations. Particular attention should be paid to ROI size and location to minimize variation among observers. Including the whole tumor volume in the ROI gives the most reproducible result.24 However, another study showed that ROI size and positioning may affect tumor ADC values, but tumor ADC can be reproducible after CRT if T2-weighted images are available to readers when analyzing post-treatment images.25

In our study, histogram parameters showed predictive value in evaluating treatment response. We observed a leftward skewness (negative skewness) in the histogram curve, a decrease in the height of the histogram peak (negative kurtosis), and an increase in ADC values as a response to CRT. Our results were consistent with the findings of the study reported by Enkhbaatar et al.26 In our study, similar to the literature data, it is observed that the mean post-CRT ADC was significantly higher than pre-CRT ADC. This is presumably due to cell death and reduction of barriers restricting the mobility of water molecules.23,26,27 In 4 of our patients, ADC values decrease unexpectedly after CRT. In 2 of these 4 patients whose histograms were right-skewed, in the histopathologic examination of the resected specimens, there were no residual tumor cells (pathological complete response). A similar situation was observed in other studies, and this observation was attributed to the increase in interstitial fibrosis, resulting in less extracellular space for the motion of water molecules. Besides the increased connective tissue production, cytotoxic edema caused by the disruption of cellular membrane depolarization at the end of the treatment can also decrease the ADC values.26,28,29

In the literature, the ADC difference has shown higher specificity and sensitivity than the mean ADC values.30 In our study, a significant difference was found between the group with minimal response and the group with complete/almost complete response in terms of ADC change (ΔADC) before and after CRT.

In the studies in which ADC histogram analysis is used in response assessment, the parameter with the best diagnostic value varies. In the study reported by Choi et al.14 a significant difference in minimum, mean ADC, 10th, 25th, 50th, and 75th percentile values were found between the complete and incomplete responders. The authors found the 25th percentile value as the parameter showing the best diagnostic performance in determining the patients with complete response. Similarly, in our study, the mean values of 25th, 50th, and 75th percentiles and the kurtosis and skewness values after CRT were significantly different between group 1 and group 3. However, the skewness value measured from the ADC histogram after treatment had the best diagnostic performance with an AUC of 0.851 to identify patients with complete response. When the cut-off value of skewness was taken as 0.210, the sensitivity of the ADC histogram in evaluating the CRT response was 100% and the specificity was 61.4%.

Our study has some limitations. First of all, our study consists of a small group (n = 51). In addition, there is an uneven distribution between the groups in the number of patients. To combine patients with almost complete and complete responses presents a bias. The study was arranged retrospectively and became open to bias in patient selection. Measuring from 3 different slices in the ADC map can be considered among the limitations of our study.

In conclusion, ADC histogram analysis seems to have potential application in predicting complete response to preoperative CRT in patients with locally advanced rectal cancer. The post-CRT skewness value of 0.210 is highly sensitive in determining the response to neoadjuvant CRT. Regarding this issue, however, larger prospective studies are needed to show which histogram parameter and the threshold value are the most useful and significant for assessing treatment response.

Footnotes

Conflict of interest disclosure The authors declared no conflicts of interest.

References

  • 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7 30. 10.3322/caac.21590) [DOI] [PubMed] [Google Scholar]
  • 2. Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg. 1996;83(3):293 304. 10.1002/bjs.1800830305) [DOI] [PubMed] [Google Scholar]
  • 3. Adam IJ, Mohamdee MO, Martin IG.et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344(8924):707 711. 10.1016/s0140-6736(94)92206-3) [DOI] [PubMed] [Google Scholar]
  • 4. Rana N, Chakravarthy AB, Kachnic LA. Neoadjuvant treatment for locally advanced rectal cancer: new concepts in clinical trial design. Curr Treat Options Oncol. 2017;18(2):13. 10.1007/s11864-017-0454-4) [DOI] [PubMed] [Google Scholar]
  • 5. Kim SH, Lee JM, Hong SH.et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology. 2009;253(1):116 125. 10.1148/radiol.2532090027) [DOI] [PubMed] [Google Scholar]
  • 6. Lambrecht M, Vandecaveye V, De Keyzer F.et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2012;82(2):863 870. 10.1016/j.ijrobp.2010.12.063) [DOI] [PubMed] [Google Scholar]
  • 7. Delli Pizzi A, Basilico R, Cianci R.et al. Rectal cancer MRI: protocols, signs and future perspectives radiologists should consider in everyday clinical practice. Insights Imaging. 2018;9(4):405 412. 10.1007/s13244-018-0606-5) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Haak HE, Maas M, Lahaye MJ.et al. Selection of patients for organ preservation after chemoradiotherapy: MRI identifies poor responders who can go straight to surgery. Ann Surg Oncol. 2020;27(8):2732 2739. 10.1245/s10434-020-08334-8) [DOI] [PubMed] [Google Scholar]
  • 9. Lambregts DMJ, Maas M, Boellaard TN.et al. Long-term imaging characteristics of clinical complete responders during watch-and-wait for rectal cancer—an evaluation of over 1500 MRIs. Eur Radiol. 2020;30(1):272 280. 10.1007/s00330-019-06396-1) [DOI] [PubMed] [Google Scholar]
  • 10. Pham TT, Liney GP, Wong K, Barton MB. Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer. Br J Radiol. 2017;90(1072):20151078. 10.1259/bjr.20151078) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Lambregts DM, Vandecaveye V, Barbaro B.et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 2011;18(8):2224 2231. 10.1245/s10434-011-1607-5) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Nerad E, Delli Pizzi A, Lambregts DMJ.et al. The apparent diffusion coefficient (ADC) is a useful biomarker in predicting metastatic colon cancer using the ADC-value of the primary tumor. PLoS ONE. 2019;14(2):e0211830. 10.1371/journal.pone.0211830) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Chidambaram V, Brierley JD, Cummings B.et al. Investigation of volumetric apparent diffusion coefficient histogram analysis for assessing complete response and clinical outcomes following pre-operative chemoradiation treatment for rectal carcinoma. Abdom Radiol (NY). 2017;42(5):1310 1318. 10.1007/s00261-016-1010-6) [DOI] [PubMed] [Google Scholar]
  • 14. Choi MH, Oh SN, Rha SE.et al. Diffusion-weighted imaging: apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer. J Magn Reson Imaging. 2016;44(1):212 220. 10.1002/jmri.25117) [DOI] [PubMed] [Google Scholar]
  • 15. Delli Pizzi A, Cianci R, Genovesi D.et al. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy. Abdom Radiol (NY). 2018;43(9):2221 2230. 10.1007/s00261-018-1457-8) [DOI] [PubMed] [Google Scholar]
  • 16. Nasu K, Kuroki Y, Minami M. Diffusion-weighted imaging findings of mucinous carcinoma arising in the ano-rectal region: comparison of apparent diffusion coefficient with that of tubular adenocarcinoma. Jpn J Radiol. 2012;30(2):120 127. 10.1007/s11604-011-0023-x) [DOI] [PubMed] [Google Scholar]
  • 17. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19 23. 10.1007/s003840050072) [DOI] [PubMed] [Google Scholar]
  • 18. Roh MS, Colangelo LH, O'Connell MJ.et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009;27(31):5124 5130. 10.1200/JCO.2009.22.0467) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Maas M, Beets-Tan RG, Lambregts DM.et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29(35):4633 4640. 10.1200/JCO.2011.37.7176) [DOI] [PubMed] [Google Scholar]
  • 20. Renehan AG, Malcomson L, Emsley R.et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016;17(2):174 183. 10.1016/S1470-2045(15)00467-2) [DOI] [PubMed] [Google Scholar]
  • 21. Barbaro B, Fiorucci C, Tebala C.et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology. 2009;250(3):730 739. 10.1148/radiol.2503080310) [DOI] [PubMed] [Google Scholar]
  • 22. Wu LM, Zhu J, Hu J.et al. Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer? Int J Colorectal Dis. 2013;28(9):1225 1238. 10.1007/s00384-013-1676-y) [DOI] [PubMed] [Google Scholar]
  • 23. Napoletano M, Mazzucca D, Prosperi E.et al. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy. Abdom Radiol (NY). 2019;44(11):3664 3673. 10.1007/s00261-019-02012-4) [DOI] [PubMed] [Google Scholar]
  • 24. Lambregts DM, Beets GL, Maas M.et al. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol. 2011;21(12):2567 2574. 10.1007/s00330-011-2220-5) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Monguzzi L, Ippolito D, Bernasconi DP, Trattenero C, Galimberti S, Sironi S. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. Eur J Radiol. 2013;82(2):234 240. 10.1016/j.ejrad.2012.09.027) [DOI] [PubMed] [Google Scholar]
  • 26. Enkhbaatar NE, Inoue S, Yamamuro H.et al. MR imaging with apparent diffusion coefficient histogram analysis: evaluation of locally advanced rectal cancer after chemotherapy and radiation therapy. Radiology. 2018;288(1):129 137. 10.1148/radiol.2018171804) [DOI] [PubMed] [Google Scholar]
  • 27. Foti PV, Privitera G, Piana S.et al. Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy. Eur J Radiol Open. 2016;3:145 152. 10.1016/j.ejro.2016.06.003) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Hein PA, Kremser C, Judmaier W.et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol. 2003;45(3):214 222. 10.1016/s0720-048x(02)00231-0) [DOI] [PubMed] [Google Scholar]
  • 29. Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol. 2003;179(9):641 649. 10.1007/s00066-003-1045-9) [DOI] [PubMed] [Google Scholar]
  • 30. Amodeo S, Rosman AS, Desiato V.et al. MRI-based apparent diffusion coefficient for predicting pathologic response of rectal cancer after neoadjuvant therapy: systematic review and meta-analysis. AJR Am J Roentgenol. 2018;211(5):W205 W216. 10.2214/AJR.17.19135) [DOI] [PubMed] [Google Scholar]

Articles from Diagnostic and Interventional Radiology are provided here courtesy of Turkish Society of Radiology

RESOURCES